Risk of Second Tumors and T-Cell Lymphoma after CAR T-Cell Therapy BACKGROUND The risk of second tumors after chimeric antigen receptor (CAR) T-cell therapy, especially the risk of T-cell neoplasms related to viral vector integration, is Read More ยป